Resources

Video: Pharmaspectra’s Congress Digest – Optimize your medical congress attendance with this valuable new planning asset
Pharmaspectra’s new Congress Digests provide the earliest access to meeting abstracts and analyses on the most prominent topics, the leading presenters and Share of Scientific Voice™ for your product and competitors
Video: Pharmaspectra’s Chief Medical Officer discusses measurement of Medical Affairs impact
VIDEO: Transforming product development in rare disease
Rare Disease webinar
“The reality of different types of users requires tailored support, not a ‘one-size-fits-all’ approach.”
Large MSL survey reveals opportunities to leverage measurement in order to optimize impact
How Pharmaspectra’s scientific Centers of Excellence (CoE) analysis can transform your strategy
Pharmaspectra Chair interviewed by The Pharma Letter – ‘Ever-improving data analytics drive better patient outcomes.’
Interview for the MSL Society Conference – Our VP Medical Affairs, Joseph Laudano, discusses “The role of experience in the ability to adapt”.
Pharmaspectra interview: What makes a difference when identifying and engaging experts in rare disease?
Pharmaspectra achieves unprecedented growth in 2021, with 27 new clients and reveals plans to expand presence in the US and Europe
There’s more Rare Disease data than you probably realize
Video: Dr Tennigkeit, UCB Biosciences, discusses the importance of KOL identification and engagement in Rare Diseases
Pharmaspectra launches Experts – our faster, smarter and more intuitive KOL profiling platform
MSL Journal – Pharmaspectra’s Joseph Laudano discusses the use of analytics to measure the impact of engagement activities
Do You Really Know all the Top Experts in Rare Diseases?
Are You Seeing All the Science You Need, When You Need It?
The Increasing Importance of Generating and Accessing Real-World Evidence
To maximize KOL impact, Medical Affairs needs a digital strategy too
Pharmaspectra opens new office in Japan
Pharmaspectra Group Limited partners with IBM Watson Health to help life sciences companies with stakeholder management
Complimentary COVID-19 database
Pharmaspectra and doctor evidence team up to combine leading congress data with leading AI search technology
Pharmaspectra’s global meetings coverage
Pharmaspectra announces investment in its future growth plan

Video: Pharmaspectra’s Congress Digest – Optimize your medical congress attendance with this valuable new planning asset

Video: Pharmaspectra’s Chief Medical Officer discusses measurement of Medical Affairs impact

VIDEO: Transforming product development in rare disease

Rare Disease webinar

“The reality of different types of users requires tailored support, not a ‘one-size-fits-all’ approach.”

Large MSL survey reveals opportunities to leverage measurement in order to optimize impact

How Pharmaspectra’s scientific Centers of Excellence (CoE) analysis can transform your strategy

Pharmaspectra Chair interviewed by The Pharma Letter – ‘Ever-improving data analytics drive better patient outcomes.’

Interview for the MSL Society Conference – Our VP Medical Affairs, Joseph Laudano, discusses “The role of experience in the ability to adapt”.

Pharmaspectra interview: What makes a difference when identifying and engaging experts in rare disease?

Pharmaspectra achieves unprecedented growth in 2021, with 27 new clients and reveals plans to expand presence in the US and Europe

There’s more Rare Disease data than you probably realize

Video: Dr Tennigkeit, UCB Biosciences, discusses the importance of KOL identification and engagement in Rare Diseases

Pharmaspectra launches Experts – our faster, smarter and more intuitive KOL profiling platform

MSL Journal – Pharmaspectra’s Joseph Laudano discusses the use of analytics to measure the impact of engagement activities

Do You Really Know all the Top Experts in Rare Diseases?

Are You Seeing All the Science You Need, When You Need It?

The Increasing Importance of Generating and Accessing Real-World Evidence

To maximize KOL impact, Medical Affairs needs a digital strategy too

Pharmaspectra opens new office in Japan

Pharmaspectra Group Limited partners with IBM Watson Health to help life sciences companies with stakeholder management

Complimentary COVID-19 database

Pharmaspectra and doctor evidence team up to combine leading congress data with leading AI search technology

Pharmaspectra’s global meetings coverage

Pharmaspectra announces investment in its future growth plan